These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25014767)

  • 1. Immunomodulatory properties of pancreatic islet-derived stem cells co-cultured with T cells: Does it contribute to the pathogenesis of type 1 diabetes?
    Sariboyaci AE; Demircan PC; Gacar G; Unal ZS; Erman G; Karaoz E
    Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):179-89. PubMed ID: 25014767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes.
    Mohammadi Ayenehdeh J; Niknam B; Rasouli S; Hashemi SM; Rahavi H; Rezaei N; Soleimani M; Liaeiha A; Niknam MH; Tajik N
    Immunol Lett; 2017 Aug; 188():21-31. PubMed ID: 28506774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory effects of adipose-derived mesenchymal stem cells on the gene expression of major transcription factors of T cell subsets.
    Mohammadzadeh A; Pourfathollah AA; Shahrokhi S; Hashemi SM; Moradi SL; Soleimani M
    Int Immunopharmacol; 2014 Jun; 20(2):316-21. PubMed ID: 24704622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells.
    Ye Z; Wang Y; Xie HY; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):608-14. PubMed ID: 19073406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoregulatory effects of human dental pulp-derived stem cells on T cells: comparison of transwell co-culture and mixed lymphocyte reaction systems.
    Demircan PC; Sariboyaci AE; Unal ZS; Gacar G; Subasi C; Karaoz E
    Cytotherapy; 2011 Nov; 13(10):1205-20. PubMed ID: 21905956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.
    Yaochite JN; de Lima KW; Caliari-Oliveira C; Palma PV; Couri CE; Simões BP; Covas DT; Voltarelli JC; Oliveira MC; Donadi EA; Malmegrim KC
    Stem Cell Res Ther; 2016 Jan; 7():14. PubMed ID: 26781648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Autoimmune T-Cell Memory by Stem Cell Educator Therapy: Phase 1/2 Clinical Trial.
    Delgado E; Perez-Basterrechea M; Suarez-Alvarez B; Zhou H; Revuelta EM; Garcia-Gala JM; Perez S; Alvarez-Viejo M; Menendez E; Lopez-Larrea C; Tang R; Zhu Z; Hu W; Moss T; Guindi E; Otero J; Zhao Y
    EBioMedicine; 2015 Dec; 2(12):2024-36. PubMed ID: 26844283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
    Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
    Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose poly I:C prevents diabetes in the diabetes prone BB rat.
    Sobel DO; Goyal D; Ahvazi B; Yoon JW; Chung YH; Bagg A; Harlan DM
    J Autoimmun; 1998 Aug; 11(4):343-52. PubMed ID: 9776712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia.
    Boumaza I; Srinivasan S; Witt WT; Feghali-Bostwick C; Dai Y; Garcia-Ocana A; Feili-Hariri M
    J Autoimmun; 2009 Feb; 32(1):33-42. PubMed ID: 19062254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic changes of the Th17/Tc17 and regulatory T cell populations interfere in the experimental autoimmune diabetes pathogenesis.
    Yaochite JN; Caliari-Oliveira C; Davanso MR; Carlos D; Malmegrim KC; Cardoso CR; Ramalho LN; Palma PV; da Silva JS; Cunha FQ; Covas DT; Voltarelli JC
    Immunobiology; 2013 Mar; 218(3):338-52. PubMed ID: 22704522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
    Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
    Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion.
    Kadle RL; Abdou SA; Villarreal-Ponce AP; Soares MA; Sultan DL; David JA; Massie J; Rifkin WJ; Rabbani P; Ceradini DJ
    PLoS One; 2018; 13(3):e0193178. PubMed ID: 29513756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow-derived mesenchymal stem cells co-cultured with pancreatic islets display β cell plasticity.
    Karaoz E; Ayhan S; Okçu A; Aksoy A; Bayazıt G; Osman Gürol A; Duruksu G
    J Tissue Eng Regen Med; 2011 Jun; 5(6):491-500. PubMed ID: 21604384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical-grade multipotent adult progenitor cells durably control pathogenic T cell responses in human models of transplantation and autoimmunity.
    Reading JL; Yang JH; Sabbah S; Skowera A; Knight RR; Pinxteren J; Vaes B; Allsopp T; Ting AE; Busch S; Raber A; Deans R; Tree TI
    J Immunol; 2013 May; 190(9):4542-52. PubMed ID: 23547116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus acceleration of murine type 1 diabetes is associated with increased MHC class I-restricted antigen presentation by B cells and elevated proinflammatory cytokine expression by T cells.
    Pane JA; Webster NL; Zufferey C; Coulson BS
    Virus Res; 2014 Jan; 179():73-84. PubMed ID: 24246305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical co-stimulatory pathways in the stability of Foxp3+ Treg cell homeostasis in Type I diabetes.
    Kornete M; Piccirillo CA
    Autoimmun Rev; 2011 Dec; 11(2):104-11. PubMed ID: 21875694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes prevention by immunomodulatory FTY720 treatment in the LEW.1AR1-iddm rat despite immune cell activation.
    Jörns A; Rath KJ; Terbish T; Arndt T; Meyer Zu Vilsendorf A; Wedekind D; Hedrich HJ; Lenzen S
    Endocrinology; 2010 Aug; 151(8):3555-65. PubMed ID: 20501676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-1-antitrypsin for the improvement of autoimmunity and allograft rejection in beta cell transplantation.
    Ye J; Liao YT; Jian YQ; Zhang XD; Wei P; Qi H; Deng CY; Li FR
    Immunol Lett; 2013 Feb; 150(1-2):61-8. PubMed ID: 23333354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.
    Parish CR; Freeman C; Ziolkowski AF; He YQ; Sutcliffe EL; Zafar A; Rao S; Simeonovic CJ
    Matrix Biol; 2013 Jun; 32(5):228-33. PubMed ID: 23499527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.